Skip to main content
. 2015 May;18(5):465–471.

Table 2.

Frequency of haplotypes emerging from two FOXP3 polymorphisms in patients with lung cancer in comparison to healthy control group

Gender FOXP3 haplotype (-2383 C/T, IVS9+459 T/C) Lung cancer patients n (%) Control group n (%) P-value
Male (n=126) CT 68 (54.0) 63 (50.0) 0.17
TT 15 (11.9) 8 (6.3)
CC 42 (33.3) 55 (43.7)
TC 1 (0.8) 0.0
Female (2n=60) CT 38 (63.3) 36 (60.0) 0.42
TT 6 (10.0) 3 (5.0)
CC 16 (26.7) 21 (35.0)
TC 0.0 0.0